サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：禁煙と脱ニコチン中毒市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2022年～2031年）
市場調査レポート
商品コード
1121629

禁煙と脱ニコチン中毒市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2022年～2031年）

Smoking Cessation and Nicotine De-Addiction Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
出版日: | 発行: Transparency Market Research | ページ情報: 英文 375 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.97円
禁煙と脱ニコチン中毒市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2022年～2031年）
出版日: 2022年07月01日
発行: Transparency Market Research
ページ情報: 英文 375 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界の禁煙と脱ニコチン中毒市場について調査し、市場の概要とともに、2022年～2031年の予測、製品タイプ別、流通チャネル別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 序文

第2章 仮定

第3章 調査手法

第4章 エグゼクティブサマリー

第5章 市場概要

  • 市場力学
  • 主要動向分析
  • 主要な市場指標
  • ポーターのファイブフォース分析
  • バリューチェーン分析
  • 業界のSWOT分析
  • 世界の禁煙と脱ニコチン中毒の市場分析、2017年～2031年

第6章 世界の禁煙と脱ニコチン中毒市場の分析と予測、製品タイプ別

  • 世界の禁煙と脱ニコチン中毒市場規模（100万米ドル）、製品タイプ別、2017年～2031年
    • 商品（ニコチン入り）
    • 製品（ニコチンなし）
  • 製品タイプ別機会

第7章 世界の禁煙と脱ニコチン中毒市場の分析と予測、流通チャネル別

  • 世界の禁煙と脱ニコチン中毒市場規模（100万米ドル）、流通チャネル別、2017年～2031年
    • オンライン
    • オフライン
  • 流通チャネル別機会

第8章 世界の禁煙と脱ニコチン中毒市場の分析と予測、地域別

  • 世界の禁煙と脱ニコチン中毒市場規模（100万米ドル）、地域別、2017年～2031年
    • 北米
    • 欧州
    • アジア太平洋
    • 中東・アフリカ
    • 南米
  • 地域別機会

第9章 北米の禁煙と脱ニコチン中毒市場の分析と予測

第10章 欧州の禁煙と脱ニコチン中毒市場の分析と予測

第11章 アジア太平洋の禁煙と脱ニコチン中毒市場の分析と予測

第12章 中東・アフリカの禁煙と脱ニコチン中毒市場の分析と予測

第13章 南米の禁煙と脱ニコチン中毒市場の分析と予測

第14章 競合情勢

  • 市場参入企業-競合ダッシュボード
  • 企業プロファイル
    • Pfizer Inc.
    • GlaxoSmithKline plc（GSK）
    • Cipla Ltd.
    • Johnson &Johnson（J&J）
    • ITC Ltd.
    • Takeda Pharmaceutical Company Ltd
    • Alkalon A/S
    • 22nd Century Group, Inc.
    • Strides Pharma Science Ltd
    • JUUL Labs, Inc.

第15章 重要ポイント

図表

List of Tables

  • Table 1: Global Smoking Cessation and Nicotine De-Addiction Market Value, by product Type, US$ Mn, 2017-2031
  • Table 2: Global Smoking Cessation and Nicotine De-Addiction Market Value, by Distribution Channel, US$ Mn,2017-2031
  • Table 3: Global Smoking Cessation and Nicotine De-Addiction Market Value, by Region, US$ Mn, 2017-2031
  • Table 4: North America Smoking Cessation and Nicotine De-Addiction Market Value, by product Type, US$ Mn, 2017-2031
  • Table 5: North America Smoking Cessation and Nicotine De-Addiction Market Value, by Distribution Channel, US$ Mn,2017-2031
  • Table 6: North America Smoking Cessation and Nicotine De-Addiction Market Value, by Country and Sub-Region, US$ Mn, 2017-2031
  • Table 7: Europe Smoking Cessation and Nicotine De-Addiction Market Value, by product Type, US$ Mn, 2017-2031
  • Table 8: Europe Smoking Cessation and Nicotine De-Addiction Market Value, by Distribution Channel, US$ Mn,2017-2031
  • Table 9: Europe Smoking Cessation and Nicotine De-Addiction Market Value, by Country and Sub-Region, US$ Mn, 2017-2031
  • Table 10: Asia Pacific Smoking Cessation and Nicotine De-Addiction Market Value, by product Type, US$ Mn, 2017-2031
  • Table 11: Asia Pacific Smoking Cessation and Nicotine De-Addiction Market Value, by Distribution Channel, US$ Mn,2017-2031
  • Table 12: Asia Pacific Smoking Cessation and Nicotine De-Addiction Market Value, by Country and Sub-Region, US$ Mn, 2017-2031
  • Table 15: MEA Smoking Cessation and Nicotine De-Addiction Market Value, by product Type, US$ Mn, 2017-2031
  • Table 16: MEA Smoking Cessation and Nicotine De-Addiction Market Value, by Distribution Channel, US$ Mn,2017-2031
  • Table 17: MEA Smoking Cessation and Nicotine De-Addiction Market Value, by Country and Sub-Region, US$ Mn, 2017-2031
  • Table 18: South America Smoking Cessation and Nicotine De-Addiction Market Value, by product Type, US$ Mn, 2017-2031
  • Table 19: South America Smoking Cessation and Nicotine De-Addiction Market Value, by Distribution Channel, US$ Mn,2017-2031
  • Table 20: South America Smoking Cessation and Nicotine De-Addiction Market Value, by Country and Sub-Region, US$ Mn, 2017-2031

List of Figures

  • Figure 1: Global Smoking Cessation and Nicotine De-Addiction Market Value, by product Type, US$ Mn, 2017-2031
  • Figure 2: Global Smoking Cessation and Nicotine De-Addiction Market Incremental Opportunity, by product Type, 2022-2031
  • Figure 3: Global Smoking Cessation and Nicotine De-Addiction Market Value, by Distribution Channel, US$ Mn, 2017-2031
  • Figure 4: Global Smoking Cessation and Nicotine De-Addiction Market Incremental Opportunity, by Distribution Channel, 2022-2031
  • Figure 5: Global Smoking Cessation and Nicotine De-Addiction Market Value, by Region, US$ Mn, 2017-2031
  • Figure 6: Global Smoking Cessation and Nicotine De-Addiction Market Incremental Opportunity, by Region,2022-2031
  • Figure 7: North America Smoking Cessation and Nicotine De-Addiction Market Value, by product Type, US$ Mn, 2017-2031
  • Figure 8: North America Smoking Cessation and Nicotine De-Addiction Market Incremental Opportunity, by product Type, 2022-2031
  • Figure 9: North America Smoking Cessation and Nicotine De-Addiction Market Value, by Distribution Channel, US$ Mn, 2017-2031
  • Figure 10: North America Smoking Cessation and Nicotine De-Addiction Market Incremental Opportunity, by Distribution Channel, 2021-2031
  • Figure 11: North America Smoking Cessation and Nicotine De-Addiction Market Value, by Country and Sub-region, US$ Mn, 2017-2031
  • Figure 12: North America Smoking Cessation and Nicotine De-Addiction Market Incremental Opportunity, by Country and Sub-region, 2022-2031
  • Figure 13: Europe Smoking Cessation and Nicotine De-Addiction Market Value, by product Type, US$ Mn, 2017-2031
  • Figure 14: Europe Smoking Cessation and Nicotine De-Addiction Market Incremental Opportunity, by product Type, 2022-2031
  • Figure 15: Europe Smoking Cessation and Nicotine De-Addiction Market Value, by Distribution Channel, US$ Mn, 2017-2031
  • Figure 16: Europe Smoking Cessation and Nicotine De-Addiction Market Incremental Opportunity, by Distribution Channel, 2022-2031
  • Figure 17: Europe Smoking Cessation and Nicotine De-Addiction Market Value, by Country and Sub-region, US$ Mn, 2017-2031
  • Figure 18: Europe Smoking Cessation and Nicotine De-Addiction Market Incremental Opportunity, by Country and Sub-region, 2022-2031
  • Figure 19: Asia Pacific Smoking Cessation and Nicotine De-Addiction Market Value, by product Type, US$ Mn, 2017-2031
  • Figure 20: Asia Pacific Smoking Cessation and Nicotine De-Addiction Market Incremental Opportunity, by product Type, 2022-2031
  • Figure 21: Asia Pacific Smoking Cessation and Nicotine De-Addiction Market Value, by Distribution Channel, US$ Mn, 2017-2031
  • Figure 22: Asia Pacific Smoking Cessation and Nicotine De-Addiction Market Incremental Opportunity, by Distribution Channel, 2022-2031
  • Figure 23: Asia Pacific Smoking Cessation and Nicotine De-Addiction Market Value, by Country and Sub-region, US$ Mn, 2017-2031
  • Figure 24: Asia Pacific Smoking Cessation and Nicotine De-Addiction Market Incremental Opportunity, by Country and Sub-region, 2022-2031
  • Figure 25: MEA Smoking Cessation and Nicotine De-Addiction Market Value, by product Type, US$ Mn, 2017-2031
  • Figure 26: MEA Smoking Cessation and Nicotine De-Addiction Market Incremental Opportunity, by Product Type, 2022-2031
  • Figure 27: MEA Smoking Cessation and Nicotine De-Addiction Market Value, by Distribution Channel, US$ Mn, 2017-2031
  • Figure 28: MEA Smoking Cessation and Nicotine De-Addiction Market Incremental Opportunity, by Distribution Channel, 2022-2031
  • Figure 29: MEA Smoking Cessation and Nicotine De-Addiction Market Value, by Country and Sub-region, US$ Mn, 2017-2031
  • Figure 30: MEA Smoking Cessation and Nicotine De-Addiction Market Incremental Opportunity, by Country and Sub-region, 2022-2031
  • Figure 31: South America Smoking Cessation and Nicotine De-Addiction Market Value, by product Type, US$ Mn, 2017-2031
  • Figure 32: South America Smoking Cessation and Nicotine De-Addiction Market Incremental Opportunity, by product Type, 2022-2031
  • Figure 33: South America Smoking Cessation and Nicotine De-Addiction Market Value, by Distribution Channel, US$ Mn, 2017-2031
  • Figure 34: South America Smoking Cessation and Nicotine De-Addiction Market Incremental Opportunity, by Distribution Channel, 2022-2031
  • Figure 35: South America Smoking Cessation and Nicotine De-Addiction Market Value, by Country and Sub-region, US$ Mn, 2017-2031
  • Figure 36: South America Smoking Cessation and Nicotine De-Addiction Market Incremental Opportunity, by Country and Sub-region, 2022-2031
目次
Product Code: TMRGL1849

The report provides revenue of the global smoking cessation and nicotine de-addiction market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global smoking cessation and nicotine de-addiction market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the smoking cessation and nicotine de-addiction market.

The report delves into the competitive landscape of the global smoking cessation and nicotine de-addiction market. Key players operating in the global smoking cessation and nicotine de-addiction market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global smoking cessation and nicotine de-addiction market profiled in this report.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions

3. Research Methodology

4. Executive Summary

5. Market Overview

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
    • 5.1.2. Restraints
    • 5.1.3. Opportunities
  • 5.2. Key Trends Analysis
    • 5.2.1. Demand Side Analysis
    • 5.2.2. Supply Side Analysis
  • 5.3. Key Market Indicators
  • 5.4. Porter's Five Forces Analysis
  • 5.5. Value Chain Analysis
  • 5.6. Industry SWOT Analysis
  • 5.7. Global Smoking Cessation and Nicotine De-Addiction Market Analysis, 2017-2031
    • 5.7.1. Market Value Projections (US$ Mn)

6. Global Smoking Cessation and Nicotine De-Addiction Market Analysis and Forecast, by Product Type

  • 6.1. Global Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Product Type, 2017-2031
    • 6.1.1. Product (with nicotine)
      • 6.1.1.1. OTC Products
        • 6.1.1.1.1. E-cigarettes
        • 6.1.1.1.2. Nicotine Gums (NRT)
        • 6.1.1.1.3. Nicotine Patches (NRT)
        • 6.1.1.1.4. Nicotine Lozenges (NRT)
        • 6.1.1.1.5. Nicotine Tablets (NRT)
      • 6.1.1.2. Prescription Products
        • 6.1.1.2.1. Nicotine Sprays (NRT)
        • 6.1.1.2.2. Nicotine Inhalers (NRT)
    • 6.1.2. Product (without nicotine)
      • 6.1.2.1. Prescription Products
        • 6.1.2.1.1. Zyban
        • 6.1.2.1.2. Chantix
  • 6.2. Incremental Opportunity, by Product Type

7. Global Smoking Cessation and Nicotine De-Addiction Market Analysis and Forecast, by Distribution Channel

  • 7.1. Global Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn)t, By Distribution Channel, 2017-2031
    • 7.1.1. Online
    • 7.1.2. Offline
  • 7.2. Incremental Opportunity, by Distribution Channel

8. Global Smoking Cessation and Nicotine De-Addiction Market Analysis and Forecast, Region

  • 8.1. Global Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Region, 2017-2031
    • 8.1.1. North America
    • 8.1.2. Europe
    • 8.1.3. Asia Pacific
    • 8.1.4. Middle East & Africa
    • 8.1.5. South America
  • 8.2. Incremental Opportunity, by Region

9. North America Smoking Cessation and Nicotine De-Addiction Market Analysis and Forecast

  • 9.1. Regional Snapshot
  • 9.2. Price Trend Analysis
    • 9.2.1. Weighted Average Selling Price (US$)
  • 9.3. Key Trends Analysis
    • 9.3.1. Demand Side Analysis
    • 9.3.2. Supply Side Analysis
  • 9.4. COVID-19 Impact Analysis
  • 9.5. Key Supplier Analysis
  • 9.6. Consumer Buying Behavior Analysis
  • 9.7. Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Product Type, 2017-2031
    • 9.7.1. Product (with nicotine)
      • 9.7.1.1. OTC Products
        • 9.7.1.1.1. E-cigarettes
        • 9.7.1.1.2. Nicotine Gums (NRT)
        • 9.7.1.1.3. Nicotine Patches (NRT)
        • 9.7.1.1.4. Nicotine Lozenges (NRT)
        • 9.7.1.1.5. Nicotine Tablets (NRT)
      • 9.7.1.2. Prescription Products
        • 9.7.1.2.1. Nicotine Sprays (NRT)
        • 9.7.1.2.2. Nicotine Inhalers (NRT)
    • 9.7.2. Product (without nicotine)
      • 9.7.2.1. Prescription Products
        • 9.7.2.1.1. Zyban
        • 9.7.2.1.2. Chantix
  • 9.8. Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Distribution Channel, 2017-2031
    • 9.8.1. Online
    • 9.8.2. Offline
  • 9.9. Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Country and Sub-region, 2017-2031
    • 9.9.1. U.S.
    • 9.9.2. Canada
    • 9.9.3. Rest of North America
  • 9.10. Incremental Opportunity Analysis

10. Europe Smoking Cessation and Nicotine De-Addiction Market Analysis and Forecast

  • 10.1. Regional Snapshot
  • 10.2. Price Trend Analysis
    • 10.2.1. Weighted Average Selling Price (US$)
  • 10.3. Key Trends Analysis
    • 10.3.1. Demand Side Analysis
    • 10.3.2. Supply Side Analysis
  • 10.4. COVID-19 Impact Analysis
  • 10.5. Key Supplier Analysis
  • 10.6. Consumer Buying Behavior Analysis
  • 10.7. Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Product Type, 2017-2031
    • 10.7.1. Product (with nicotine)
      • 10.7.1.1. OTC Products
        • 10.7.1.1.1. E-cigarettes
        • 10.7.1.1.2. Nicotine Gums (NRT)
        • 10.7.1.1.3. Nicotine Patches (NRT)
        • 10.7.1.1.4. Nicotine Lozenges (NRT)
        • 10.7.1.1.5. Nicotine Tablets (NRT)
      • 10.7.1.2. Prescription Products
        • 10.7.1.2.1. Nicotine Sprays (NRT)
        • 10.7.1.2.2. Nicotine Inhalers (NRT)
    • 10.7.2. Product (without nicotine)
      • 10.7.2.1. Prescription Products
        • 10.7.2.1.1. Zyban
        • 10.7.2.1.2. Chantix
  • 10.8. Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2031
    • 10.8.1. Online
    • 10.8.2. Offline
  • 10.9. Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Country and Sub-region, 2017-2031
    • 10.9.1. U.K.
    • 10.9.2. Germany
    • 10.9.3. France
    • 10.9.4. Rest of Europe
  • 10.10. Incremental Opportunity Analysis

11. Asia Pacific Smoking Cessation and Nicotine De-Addiction Market Analysis and Forecast

  • 11.1. Regional Snapshot
  • 11.2. Price Trend Analysis
    • 11.2.1. Weighted Average Selling Price (US$)
  • 11.3. Key Trends Analysis
    • 11.3.1. Demand Side Analysis
    • 11.3.2. Supply Side Analysis
  • 11.4. COVID-19 Impact Analysis
  • 11.5. Key Supplier Analysis
  • 11.6. Consumer Buying Behavior Analysis
  • 11.7. Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Product Type, 2017-2031
    • 11.7.1. Product (with nicotine)
      • 11.7.1.1. OTC Products
        • 11.7.1.1.1. E-cigarettes
        • 11.7.1.1.2. Nicotine Gums (NRT)
        • 11.7.1.1.3. Nicotine Patches (NRT)
        • 11.7.1.1.4. Nicotine Lozenges (NRT)
        • 11.7.1.1.5. Nicotine Tablets (NRT)
      • 11.7.1.2. Prescription Products
        • 11.7.1.2.1. Nicotine Sprays (NRT)
        • 11.7.1.2.2. Nicotine Inhalers (NRT)
    • 11.7.2. Product (without nicotine)
      • 11.7.2.1. Prescription Products
        • 11.7.2.1.1. Zyban
        • 11.7.2.1.2. Chantix
  • 11.8. Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Distribution Channel, 2017-2031
    • 11.8.1. Online
    • 11.8.2. Offline
  • 11.9. Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Country and Sub-region, 2017-2031
    • 11.9.1. China
    • 11.9.2. India
    • 11.9.3. Japan
    • 11.9.4. Rest of Asia Pacific
  • 11.10. Incremental Opportunity Analysis

12. Middle East & Africa Smoking Cessation and Nicotine De-Addiction Market Analysis and Forecast

  • 12.1. Regional Snapshot
  • 12.2. Price Trend Analysis
    • 12.2.1. Weighted Average Selling Price (US$)
  • 12.3. Key Trends Analysis
    • 12.3.1. Demand Side Analysis
    • 12.3.2. Supply Side Analysis
  • 12.4. COVID-19 Impact Analysis
  • 12.5. Key Supplier Analysis
  • 12.6. Consumer Buying Behavior Analysis
  • 12.7. Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Product Type, 2017-2031
    • 12.7.1. Product (with nicotine)
      • 12.7.1.1. OTC Products
        • 12.7.1.1.1. E-cigarettes
        • 12.7.1.1.2. Nicotine Gums (NRT)
        • 12.7.1.1.3. Nicotine Patches (NRT)
        • 12.7.1.1.4. Nicotine Lozenges (NRT)
        • 12.7.1.1.5. Nicotine Tablets (NRT)
      • 12.7.1.2. Prescription Products
        • 12.7.1.2.1. Nicotine Sprays (NRT)
        • 12.7.1.2.2. Nicotine Inhalers (NRT)
    • 12.7.2. Product (without nicotine)
      • 12.7.2.1. Prescription Products
        • 12.7.2.1.1. Zyban
        • 12.7.2.1.2. Chantix
  • 12.8. Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Distribution Channel, 2017-2031
    • 12.8.1. Online
    • 12.8.2. Offline
  • 12.9. Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Country and Sub-region, 2017-2031
    • 12.9.1. GCC
    • 12.9.2. South Africa
    • 12.9.3. Rest of Middle East & Africa
  • 12.10. Incremental Opportunity Analysis

13. South America Smoking Cessation and Nicotine De-Addiction Market Analysis and Forecast

  • 13.1. Regional Snapshot
  • 13.2. Price Trend Analysis
    • 13.2.1. Weighted Average Selling Price (US$)
  • 13.3. Key Trends Analysis
    • 13.3.1. Demand Side Analysis
    • 13.3.2. Supply Side Analysis
  • 13.4. COVID-19 Impact Analysis
  • 13.5. Key Supplier Analysis
  • 13.6. Consumer Buying Behavior Analysis
  • 13.7. Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Product Type, 2017-2031
    • 13.7.1. Product (with nicotine)
      • 13.7.1.1. OTC Products
        • 13.7.1.1.1. E-cigarettes
        • 13.7.1.1.2. Nicotine Gums (NRT)
        • 13.7.1.1.3. Nicotine Patches (NRT)
        • 13.7.1.1.4. Nicotine Lozenges (NRT)
        • 13.7.1.1.5. Nicotine Tablets (NRT)
      • 13.7.1.2. Prescription Products
        • 13.7.1.2.1. Nicotine Sprays (NRT)
        • 13.7.1.2.2. Nicotine Inhalers (NRT)
    • 13.7.2. Product (without nicotine)
      • 13.7.2.1. Prescription Products
        • 13.7.2.1.1. Zyban
        • 13.7.2.1.2. Chantix
  • 13.8. Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Distribution Channel, 2017-2031
    • 13.8.1. Online
    • 13.8.2. Offline
  • 13.9. Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Country and Sub-region, 2017-2031
    • 13.9.1. Brazil
    • 13.9.2. Rest of South America
  • 13.10. Incremental Opportunity Analysis

14. Competition Landscape

  • 14.1. Market Player - Competition Dashboard
  • 14.2. Company Profiles (Details - Company Overview, Sales Area/Geographical Presence, Financial/Revenue, Strategy & Business Overview, Sales Channel Analysis, Size Portfolio)
    • 14.2.1. Pfizer Inc.
      • 14.2.1.1. Company Overview
      • 14.2.1.2. Sales Area/Geographical Presence
      • 14.2.1.3. Financial/Revenue
      • 14.2.1.4. Strategy & Business Overview
      • 14.2.1.5. Sales Channel Analysis
      • 14.2.1.6. Size Portfolio
    • 14.2.2. GlaxoSmithKline plc (GSK)
      • 14.2.2.1. Company Overview
      • 14.2.2.2. Sales Area/Geographical Presence
      • 14.2.2.3. Financial/Revenue
      • 14.2.2.4. Strategy & Business Overview
      • 14.2.2.5. Sales Channel Analysis
      • 14.2.2.6. Size Portfolio
    • 14.2.3. Cipla Ltd.
      • 14.2.3.1. Company Overview
      • 14.2.3.2. Sales Area/Geographical Presence
      • 14.2.3.3. Financial/Revenue
      • 14.2.3.4. Strategy & Business Overview
      • 14.2.3.5. Sales Channel Analysis
      • 14.2.3.6. Size Portfolio
    • 14.2.4. Johnson & Johnson (J&J)
      • 14.2.4.1. Company Overview
      • 14.2.4.2. Sales Area/Geographical Presence
      • 14.2.4.3. Financial/Revenue
      • 14.2.4.4. Strategy & Business Overview
      • 14.2.4.5. Sales Channel Analysis
      • 14.2.4.6. Size Portfolio
    • 14.2.5. ITC Ltd.
      • 14.2.5.1. Company Overview
      • 14.2.5.2. Sales Area/Geographical Presence
      • 14.2.5.3. Financial/Revenue
      • 14.2.5.4. Strategy & Business Overview
      • 14.2.5.5. Sales Channel Analysis
      • 14.2.5.6. Size Portfolio
    • 14.2.6. Takeda Pharmaceutical Company Ltd
      • 14.2.6.1. Company Overview
      • 14.2.6.2. Sales Area/Geographical Presence
      • 14.2.6.3. Financial/Revenue
      • 14.2.6.4. Strategy & Business Overview
      • 14.2.6.5. Sales Channel Analysis
      • 14.2.6.6. Size Portfolio
    • 14.2.7. Alkalon A/S
      • 14.2.7.1. Company Overview
      • 14.2.7.2. Sales Area/Geographical Presence
      • 14.2.7.3. Financial/Revenue
      • 14.2.7.4. Strategy & Business Overview
      • 14.2.7.5. Sales Channel Analysis
      • 14.2.7.6. Size Portfolio
    • 14.2.8. 22nd Century Group, Inc.
      • 14.2.8.1. Company Overview
      • 14.2.8.2. Sales Area/Geographical Presence
      • 14.2.8.3. Financial/Revenue
      • 14.2.8.4. Strategy & Business Overview
      • 14.2.8.5. Sales Channel Analysis
      • 14.2.8.6. Size Portfolio
    • 14.2.9. Strides Pharma Science Ltd
      • 14.2.9.1. Company Overview
      • 14.2.9.2. Sales Area/Geographical Presence
      • 14.2.9.3. Financial/Revenue
      • 14.2.9.4. Strategy & Business Overview
      • 14.2.9.5. Sales Channel Analysis
      • 14.2.9.6. Size Portfolio
    • 14.2.10. JUUL Labs, Inc.
      • 14.2.10.1. Company Overview
      • 14.2.10.2. Sales Area/Geographical Presence
      • 14.2.10.3. Financial/Revenue
      • 14.2.10.4. Strategy & Business Overview
      • 14.2.10.5. Sales Channel Analysis
      • 14.2.10.6. Size Portfolio

15. Key Takeaway